Liberian man in Nigeria's Lagos being tested for Ebola

by Reuters
Thursday, 24 July 2014 15:17 GMT

Diagram illustrating the life cycle of the Ebola virus disease and its route of transmission to humans

Image Caption and Rights Information

(Adds details, background)

LAGOS, July 24 (Reuters) - A Liberian man in his 40s is being tested for the deadly Ebola virus in Nigeria's commercial capital of Lagos, a megacity of 21 million people, the Lagos State Health Ministry said on Thursday.

Ebola has killed 632 people across Guinea, Liberia and Sierra Leone since an outbreak began in February, straining a string of weak health systems despite international help.

This would be the first recorded case of one of the world's deadliest diseases in Nigeria, Africa's biggest economy and most populous nation with 170 million people.

Nigeria has some of the continent's least adequate health infrastructure for a nation of its size, despite access to billions of dollars of oil money as Africa's biggest oil producer.

The special adviser on public health to the Lagos state government, Yewande Adeshina, told a news conference the man had arrived in Lagos from Liberia on Sunday.

"The patient was admitted and detained on suspicion of possible EBV (Ebola) infection, while blood sample collection and testing was initiated," she said in her statement.

Samples had been sent to a World Health Organisation (WHO) laboratory in Dakar, she said, adding that "results are pending."

The Ebola outbreak started in Guinea's remote southeast and has since spread across the region's poorly controlled borders. Symptoms of the highly infectious disease are diarrhoea, vomiting and internal and external bleeding. (Reporting by Chijioke Ohuocha; Writing by Tim Cocks, editing by Jeremy Gaunt)

Latest News
Comments Close
Liberian man in Nigeria's Lagos being tested for Ebola

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of the Thomson Reuters Foundation. For more information see our Acceptable Use Policy.

comments powered by Disqus